Show simple item record
dc.identifier.citationLalatsa , A Sep. 10 2010 , Oral Delivery of Hydrophilic Drugs to the Brain , Patent No. WO/2010/100479 , IPC No. A61K 47/18 (2006.01), A61K 47/36 (2006.01), A61K 47/48 (2006.01) . < >
dc.identifier.otherPURE: 1269889
dc.identifier.otherPURE UUID: 5c403fcb-44b4-44a5-8d5a-d67779e92e60
dc.description.abstractA composition comprising a lipophilic derivative of a hydrophilic drug and an amphiphile compound for use in therapy wherein the composition is orally administered to the human or animal body. The invention includes derivatives such as palmitoylated Leucine[5]-Enkephalin and is useful in the treatment of schizophrenia, obsesity, pain and sleep disorders, psychiatric diseases, neurodegenerative conditions, brain cancers and infective diseases.en
dc.subject.classificationA61K 47/18 (2006.01), A61K 47/36 (2006.01), A61K 47/48 (2006.01)
dc.titleOral Delivery of Hydrophilic Drugs to the Brainen
dc.contributor.institutionCentre for Research into Topical Drug Delivery and Toxicology
dc.contributor.institutionDepartment of Pharmacy
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionHealth & Human Sciences Research Institute
dc.contributor.inventorLalatsa, Aikaterini

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record